NaPDI | Compound details

Need public description.

Natural products containing this compound

Enantiomer of compound
None listed

Compound has enantiomers
None listed

Metabolite of compounds
None listed

Compound has metabolites
None listed

ID	Subject of Study	Study Name	Name	Type	Overall Effect	Enzymes	Transporters	Object	Object Metabolite	Precipitant
NPDI-FJjrAg	Goldenseal (Hydrastis canadensis)	The Effects of Berberine on the Pharmacokinetics of Ciclosporin A in Healthy Volunteers	CsA 6 mg/kg Experiment	In Vivo Interaction	negative — No Effect (based on bioequivalence limits)	CYP3A4	P-gp (ABCB1)	cyclosporin a		berberine
NPDI-6IV4Kg	Goldenseal (Hydrastis canadensis)	The Effects of Berberine on the Pharmacokinetics of Ciclosporin A in Healthy Volunteers	CsA 3 mg/kg Experiement	In Vivo Interaction	positive — PK Interaction - Increased systemic exposure	CYP3A4	P-gp (ABCB1)	cyclosporin a		berberine
NPDI-uJn2xw	Goldenseal (Hydrastis canadensis)	Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study	CsA in Renal Transplant patients	In Vivo Interaction	positive — PK Interaction - Increased systemic exposure			cyclosporin a		berberine
NPDI-C2C-Nw	Goldenseal (Hydrastis canadensis)	Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study	CsA Trough measurements in 52 patients	In Vivo Interaction	positive — PK Interaction - Increased systemic exposure			cyclosporin a		berberine

ID	Subject of Study	Name
NPDI-yBr48Q	Goldenseal (Hydrastis canadensis)	The Effects of Berberine on the Pharmacokinetics of Ciclosporin A in Healthy Volunteers
NPDI-rmRb0A	Goldenseal (Hydrastis canadensis)	Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study

Compound information from external resources

Resource	Identifier
Google search	PMATZTZNYRCHOR-CGLBZJNRSA-N